Alina C. Boesteanu - Concepedia

Author

Alina C. Boesteanu

Also Known As

A Boesteanu, A. Boesteanu, ALINA BOESTEANU, ALINA C BOESTEANU, Alina Boesteanu, Alina C Boesteanu, Alina C. Boesteanu, Alina C. Boesteanu

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

University of Pennsylvania Drexel University Pennsylvania State University Parker Institute for Cancer Immunotherapy Penn State Milton S. Hershey Medical Center

About

Alina C. Boesteanu is an author at University of Pennsylvania specializing in immunology, medicine, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	15	5.3K
2	Engineering	1	1	40
3	Natural Sciences	1	1	56
4	Allergy	1	1	174
5	Biochemistry	1	1	56

Alina C. Boesteanu

Publications

7.2K

Citations

H-Index

Page 1

	Year	Citations
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando, Nature Medicine T Cell TherapyCancer ImmunosurveillanceChronic Lymphocytic LeukemiaHematologyImmunology	2018	1.7K
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide Martha S. Jordan, Alina C. Boesteanu, Amy J. Reed, Nature Immunology Signal TransductionAutoimmune DiseaseLymphocyte DevelopmentT-regulatory CellImmunology	2001	1.6K
CD1d1 Mutant Mice Are Deficient in Natural T Cells That PromptlyProduce IL-4 Sanjeev Kumar Mendiratta, William Martin, Seokmann Hong, Immunity InflammationPromptlyproduce Il-4Lymphocyte DevelopmentT-regulatory CellNatural T Cells	1997	593
Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma Avery D. Posey, Robert D. Schwab, Alina C. Boesteanu, Immunity Cancer ImmunosurveillanceOncogenic AgentMedicineImmunologyImmunotherapy	2016	572
Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma Laura A. Johnson, John Scholler, Takayuki Ohkuri, Science Translational Medicine	2015	448
Natural Ligand of Mouse CD1d1: Cellular Glycosylphosphatidylinositol Sebastian Joyce, Amina S. Woods, Jonathan W. Yewdell, Science	1998	393
The microRNA miR-155 controls CD8+ T cell responses by regulating interferon signaling Donald T. Gracias, Erietta Stelekati, Jennifer L. Hope, Nature Immunology ImmunologyLong Non-coding RnaCd4 T Cell ResponsesMicrorna DetectionSmall Rna	2013	271
The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis Carol M. Artlett, Sihem Sassi‐Gaha, Judy Rieger, Arthritis & Rheumatism	2011	197
Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas Yibo Yin, Alina C. Boesteanu, Zev A. Binder, Molecular Therapy — Oncolytics	2018	175
Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion Christine M. Bucks, Jillian Norton, Alina C. Boesteanu, The Journal of Immunology Adaptive Immune SystemT-regulatory CellViral ImmunityImmunologyT Cells	2009	174

Page 1